TRENTRON BIOMEDICAL LTD.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Focusing on Point-of-Care Testing (POCT) for infectious diseases, with Credo Biomedical responsible for research and development (R&D) and global marketing strategies, and TRENTRON BIOMEDICAL LTD. responsible for manufacturing.
1. Rapid nucleic acid testing platform;
2. Rapid qualitative and quantitative protein testing platform;
3. Automated nucleic acid extraction platform.
(The content above was translated by AI.)
1. Rapid nucleic acid testing platform;
2. Rapid qualitative and quantitative protein testing platform;
3. Automated nucleic acid extraction platform.
(The content above was translated by AI.)
Founded Year
2014
Unified Business No.
54674621
Status
Closed
Number of Employees
50
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
TRENTRON BIOMEDICAL LTD. was established in Taiwan in 2014. With development and production technologies transferred from Singapore-based Credo Diagnostics Biomedical Pte. Ltd., the company is dedicated to the manufacturing of in vitro diagnostic/point-of-care testing (IVD/POCT) products and serves as the primary manufacturing base for the Credo Diagnostics Biomedical Group.
Credo Diagnostics Biomedical was established in Singapore in 2011. With "ADVANCED MEDICAL TECHNOLOGY FOR ALL." as its core philosophy, the company focuses on comprehensive solutions for infectious disease point-of-care testing (POCT). It aims to popularize advanced medical technology so that everyone can enjoy convenient testing services. The innovative technology platform developed by the company, the VitaPCR™ Instrument, is a leading brand globally and one of the few capable of providing "nucleic acid detection completed within 20 minutes" technology. In addition to the advantages of being fast, accurate, and portable, the VitaPCR™ Instrument is also paired with detection kits featuring virus-inactivating sample preservation solution and PCR reaction reagents that can be stored at room temperature, while its corresponding software provides real-time data management functions.
TRENTRON BIOMEDICAL LTD. is located in the Xizhi Science Park in New Taipei City, possessing a reagent production and instrument assembly facility of over 3,900 pings. It is equipped with a Class 100,000 cleanroom and an ISO 13485 internationally certified manufacturing plant, and has passed international GMP certification.
(The content above was translated by AI.)
Credo Diagnostics Biomedical was established in Singapore in 2011. With "ADVANCED MEDICAL TECHNOLOGY FOR ALL." as its core philosophy, the company focuses on comprehensive solutions for infectious disease point-of-care testing (POCT). It aims to popularize advanced medical technology so that everyone can enjoy convenient testing services. The innovative technology platform developed by the company, the VitaPCR™ Instrument, is a leading brand globally and one of the few capable of providing "nucleic acid detection completed within 20 minutes" technology. In addition to the advantages of being fast, accurate, and portable, the VitaPCR™ Instrument is also paired with detection kits featuring virus-inactivating sample preservation solution and PCR reaction reagents that can be stored at room temperature, while its corresponding software provides real-time data management functions.
TRENTRON BIOMEDICAL LTD. is located in the Xizhi Science Park in New Taipei City, possessing a reagent production and instrument assembly facility of over 3,900 pings. It is equipped with a Class 100,000 cleanroom and an ISO 13485 internationally certified manufacturing plant, and has passed international GMP certification.
(The content above was translated by AI.)
